-- KKCGマリタイムは、香港証券取引所への水曜日の提出書類で、フェレッティ（香港証券取引所：9638）株の買収提案に対し、締め切りまでに2960万株の応募があったと発表した。これは目標としていた最大5210万株を下回る数字だ。 チェコの投資グループであるKKCGマリタイムは、イタリアのヨットメーカーであるフェレッティの株式保有比率を14.5%から29.9%に引き上げるため、1月に1株あたり3.50ユーロでの株式取得を提案していた。 その後、1株あたり3.90ユーロに修正されたこの株式公開買付けは、フェレッティ取締役会の承認を得られなかった。 KKCGマリタイムは、1億1590万ユーロで全株を取得し、保有比率を約8.75%引き上げて23.25%にすると発表した。
Related Articles
Asia
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
$ASX:NAB
Asia
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
$ASX:CUV
Asia
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.
$ASX:XRF